Welcome to
Scandinavian Biopharma

Scandinavian Biopharma is a Swedish research-based biotech company specialist in marketing and sales of vaccines, immunoglobulin’s, biodefense, antidotes and diagnostic tests.

Research and development is mainly focused on development of a new oral traveler’s diarrhea vaccine in collaboration with PATH Vaccine Solutions and University of Gothenburg.

  • Björn Sjöstrand Björn Sjöstrand
  • Björn Gustavsson Björn Gustafsson
  • helena_päärni Helena Päärni
  • mikael_vikström Mikael Vikström
  • Peter Liss sv Peter Liss
  • Tobias skarin Tobias Skarin

Guest editor for Stockholm Science City on Instagram

2018-01-14

This week, 15th – 19th January, Scandinavian Bioharma through Lisa Sandberg, is the guest editor for Stockholm Science City on Instagram sthlmscisity. Please join us during this week. https://www.instagram.com/sthlmscicity/

Our vaccine project on PATH´s DefeatDD Blog

2018-01-05

PATH´s Defeat Diarrheal Disease Initiative (DefeatDD) raise awareness of the burden of diarrheal diseases and help increase access to the solution. On the DefeatDD blog you can read the latest on global efforts to defeat diarrheal disease. This week our ongoing clinical trial in travellers going to Benin is highlighted. https://www.defeatdd.org/blog/going-straight-source-vaccine-research

Charlotte Flodin joins Scandinavian Biopharma as VP Quality Assurance

2017-11-06

Scandinavian Biopharma continues to expand and strengthen its organization. In August Charlotte Flodin started as VP Quality Assurance. – I am very excited to take part in the journey to develop a new vaccine – ETVAX®,” says Charlotte Flodin, who will be responsible for Quality Assurance. With my previous experience of drug development and manufacturing […]